ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CAPR Capricor Therapeutics Inc

6.86
0.09 (1.33%)
Last Updated: 12:12:54
Delayed by 15 minutes

Period:

Draw Mode:

Volume 79,856
Bid Price 6.85
Ask Price 6.88
News -
Day High 6.935

Low
2.68

52 Week Range

High
8.2212

Day Low 6.60
Company Name Stock Ticker Symbol Market Type
Capricor Therapeutics Inc CAPR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.09 1.33% 6.86 12:12:54
Open Price Low Price High Price Close Price Prev Close
6.74 6.60 6.935 6.77
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
789 79,856 $ 6.76 $ 540,039 - 2.68 - 8.2212
Last Trade Time Type Quantity Stock Price Currency
12:12:54 5 $ 6.86 USD

Capricor Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
215.4M 31.40M - 2.55M -29.02M -0.92 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Capricor Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CAPR Message Board. Create One! See More Posts on CAPR Message Board See More Message Board Posts

Historical CAPR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week6.927.045.806.57464,829-0.06-0.87%
1 Month4.437.224.106.09423,2362.4354.85%
3 Months5.137.223.565.25278,7101.7333.72%
6 Months5.917.222.684.24289,2350.9516.07%
1 Year4.108.22122.684.58193,7472.7667.32%
3 Years5.028.22122.564.52262,2701.8436.65%
5 Years0.576612.320.25265.89756,5466.281,089.73%

Capricor Therapeutics Description

Capricor Therapeutics, Inc. is a San Diego based biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy that is currently in late-stage clinical development for treating Duchenne muscular dystrophy (DMD). Capricor is also developing its exosome technology as a next-generation therapeutic platform. Capricor's proprietary StealthX¿ exosome platform has potential for a broad range of new therapeutic applications in the field of vaccinology as well as targeted oligonucleotide, protein and small molecule therapeutics to treat or prevent a variety of diseases.

Your Recent History

Delayed Upgrade Clock